• Date: September 12, 2018

On 6 September, CaixaForum Barcelona hosted a Pitch Day for the projects that took part in the CaixaImpulse 2017. The event offers an opportunity for participants to present their projects, in the fields of therapeutic innovation, diagnostics and medical devices, to experts from the pharmaceutical and entrepreneurship in biomedicine sectors, and receive feedback.

More specifically, the experts on hand to assess the proposals were Oliver Chao, Head of Emerging Biomedical Sciences at Sanofi; Antonio Gómez, Scientific Liaison for J&J Innovation Centers at Johnson & Johnson; Sanne de Jongh, Senior Associate at Gilde Healthcare; Erez Chimovits, Managing Director at Orbimed; Xavier Ruiz, Region Marketing Director Iberia at GE Healthcare; Yolanda Casas, Enterprise Sales Manager at Abbott, and Jon Askaa, Non-Executive Director at Inbiomotion and CMO of Medical Prognosis.

More programme highlights

February 14, 2019

GlyCardial Diagnostics wins Horizon 2020 funding

Apo J-Glyc, a project selected in CaixaImpulse 2015, is now operating as a company named GlyCardial Diagnostics.

February 12, 2019

“The entrepreneur is the one who has to choose, whether they get it right or make mistakes”

Roger Gomis from IRB talks to us about what CaixaImpulse means to him and explains more about his role as mentor.

February 04, 2019

Applications open for CaixaImpulse’s 2019 call

CaixaImpulse is seeking 25 innovative health and biomedical projects to support and develop starting in 2019.